Mediterranean diet and health status: Active ingredients and pharmacological mechanisms

L Schwingshackl, J Morze… - British journal of …, 2020 - Wiley Online Library
The Mediterranean diet (MedDiet) is one of the most widely described and evaluated dietary
patterns in scientific literature. It is characterized by high intakes of vegetables, legumes …

The butyrate story: old wine in new bottles?

W Scheppach, F Weiler - Current Opinion in Clinical Nutrition & …, 2004 - journals.lww.com
In the era of molecular biology our understanding of subcellular processes that ultimately
lead to inflammatory bowel disease or colorectal cancer has widened considerably. The …

A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase

MC Myzak, PA Karplus, FL Chung, RH Dashwood - Cancer research, 2004 - AACR
Sulforaphane (SFN), a compound found at high levels in broccoli and broccoli sprouts, is a
potent inducer of phase 2 detoxification enzymes and inhibits tumorigenesis in animal …

[HTML][HTML] Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apcmin mice

MC Myzak, WM Dashwood, GA Orner… - The FASEB journal …, 2006 - ncbi.nlm.nih.gov
We recently reported that sulforaphane (SFN), an isothiocyanate from broccoli, inhibited
HDAC activity and increased the acetylation of histone H3 and histone H4 in human colon …

Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells

MC Myzak, K Hardin, R Wang, RH Dashwood… - …, 2006 - academic.oup.com
Sulforaphane (SFN), an isothiocyanate first isolated from broccoli, exhibits chemopreventive
properties in prostate cancer cells through mechanisms that are poorly understood. We …

A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemia

JC Byrd, G Marcucci, MR Parthun, JJ Xiao, RB Klisovic… - Blood, 2005 - ashpublications.org
Preclinical studies with the histone deacetylase (HDAC) inhibitor depsipeptide (FK228) in
chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML) have demonstrated …

Mediterranean diet: prevention of colorectal cancer

MG Donovan, OI Selmin, TC Doetschman… - Frontiers in …, 2017 - frontiersin.org
Colorectal cancer (CRC) is the third most common cancer diagnosis and the second and
third leading cause of cancer mortality in men and women, respectively. However, the …

Butyrate elicits a metabolic switch in human colon cancer cells by targeting the pyruvate dehydrogenase complex

JM Blouin, G Penot, M Collinet, M Nacfer… - … journal of cancer, 2011 - Wiley Online Library
Butyrate, a short‐chain fatty acid produced by the colonic bacterial fermentation is able to
induce cell growth inhibition and differentiation in colon cancer cells at least partially through …

Histone deacetylase inhibitors up-regulate the expression of tight junction proteins

M Bordin, F D'Atri, L Guillemot, S Citi - Molecular Cancer Research, 2004 - AACR
Histone deacetylase (HDAC) inhibitors promote cell maturation, differentiation, and
apoptosis through changes in gene expression. Differentiated epithelial cells are …

Allyl mercaptan, a garlic-derived organosulfur compound, inhibits histone deacetylase and enhances Sp3 binding on the P21WAF1 promoter

H Nian, B Delage, JT Pinto, RH Dashwood - Carcinogenesis, 2008 - academic.oup.com
Histone deacetylase (HDAC) inhibitors have the potential to derepress epigenetically
silenced genes in cancer cells, leading to cell cycle arrest and apoptosis. In the present …